Galecto Inc expected to post a loss of 57 cents a share - Earnings Preview

Damora Therapeutics

13/02/2023 11:25

* Galecto Inc  GLTO.OQ   GLTO.O  is expected to show no
change in
quarterly revenue when it reports  results on February 15
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Galecto Inc is for
a loss
of 57 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Galecto Inc
is
$9​, above​ its last closing price of $2.65. ​​​

This summary was machine generated February 13 at 11:25 GMT. 
All figures in US dollars  unless otherwise stated